Go Pro

Citigroup's Rating of Attovia Therapeutics on 8/31/2026

On August 31, 2026, Citigroup updated its outlook on Attovia Therapeutics (NASDAQ:ATTO) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Citigroup Inc.

DateCompanyAction
8/31/2026
MINISO Group Holding Limited Unsponsored ADR stock logo
MNSO
MINISO Group
Downgrade
8/31/2026
Devon Energy Corporation stock logo
DVN
Devon Energy
Reiterated Rating
8/31/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated Rating
8/31/2026
Carvana Co. stock logo
CVNA
Carvana
Reiterated Rating
8/31/2026
Cloudflare, Inc. stock logo
NET
Cloudflare
Reiterated Rating
8/28/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
Boost Price Target
More Ratings From Citigroup Inc.